Hey Staypuff, the company has unfortunately given the naysayers a significant amount of an ammo over the last month. S1 delay, departing CEO with no further explanation, and what appears to be an overvalued acquisition with added shares coming. What a trifecta, huh?
However, what has changed about the core business itself over the last month? Absolutely nothing. Zilch. Nada. I know nobody cares at this point, but I bet they had another huge month in revenues for August. They're bringing in more revenue in a month at this point than a lot of OTCs make in a year.
The company has always wanted to delve deeper into the Telehealth space. They are now on track to get there (assuming the deal closes). They are building out their headquarters location and are moving the Orlando pharmacy to a facility 4x its current size for the same price. Your typical pharmacy does not need that much square footage. They are gearing up to be more than just the 'mom and pop' one-store pharmacy that they once were.
Hey, this price is a disaster right now, but gotta keep things in perspective here. For a company that has been incredibly transparent in the past, they have just really dropped the ball the last month. Throwing out all the potential deadlines on the S1 put them in a corner. They have created a sense of doubt among investors, and a strong voice is needed to calm the storm. Can Armen or Jay be that person? I don't know, but it needs to happen.
All they need to do is 1) Confirm their commitment to filing the S1 (someone show me where they can't say that) 2) Comment on the CEO search 3) Explain how this new LOI deal and how it will fit big picture and be incorporated into the current business.
That is all for now.
News 
Market Data 
Discover 
AI
